Raphael Pharmaceutical Inc (RAPH)
0.26
0.00 (0.00%)
USD |
OTCM |
Nov 21, 16:00
Raphael Pharmaceutical Net Income (Quarterly): -0.326M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.326M |
| June 30, 2024 | -0.248M |
| March 31, 2024 | -0.55M |
| December 31, 2023 | 0.122M |
| September 30, 2023 | -0.725M |
| June 30, 2023 | -0.417M |
| March 31, 2023 | -0.264M |
| December 31, 2022 | -1.915M |
| Date | Value |
|---|---|
| September 30, 2022 | -2.255M |
| June 30, 2022 | -0.627M |
| March 31, 2022 | -0.185M |
| December 31, 2021 | -0.566M |
| September 30, 2021 | -0.416M |
| June 30, 2021 | -0.642M |
| March 31, 2021 | -0.255M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-2.255M
Minimum
Sep 2022
0.122M
Maximum
Dec 2023
-0.6179M
Average
-0.417M
Median
Jun 2023
Net Income (Quarterly) Benchmarks
| InspireMD Inc | -7.89M |
| Pluri Inc | -5.882M |
| IDenta Corp | 0.1023M |
| BiomX Inc | 9.642M |
| IR-Med Inc | -0.598M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.319M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 4.822M |
| Earnings Yield | -11.54% |